Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers

Sponsor
Hadassah Medical Organization (Other)
Overall Status
Unknown status
CT.gov ID
NCT00429208
Collaborator
(none)
40
1
1.9
20.6

Study Details

Study Description

Brief Summary

This research project addresses the hypothesis that a neurocognitive profile characterized by impairment of response inhibition and sustained attention may be a risk factor for smoking initiation and nicotine dependence among young women. Nicotine has short- term, facilitating effects on attention and response inhibition. Therefore, individuals who are impaired on cognitive functions such as these and initiate cigarette smoking may be more likely to maintain the habit and develop nicotine dependence. The research protocol specifically tests whether administration of nicotine to non-abstinent, regular cigarette smokers improves cognitive function in those domains where the participants had previously been shown to manifest performance deficits

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Double
Primary Purpose:
Diagnostic
Official Title:
Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers: A Double-Blind, Within-Subjects, Placebo-Controlled Study
Study Start Date :
Feb 1, 2007
Anticipated Study Completion Date :
Apr 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Neurocognitive functions []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Reported smoking cigarettes on a daily basis at the time of the original study and continue to smoke currently

  • Manifested poor performance on the MFFT (The neurocognitive test that yielded differences between smokers and non-smokers)

  • Competent and willing to give written informed consent

Exclusion Criteria:
  • Pregnancy, breast-feeding, non-use of contraception such that the possibility of pregnancy cannot be excluded

  • Intake of any medication that may potentially interact with nicotine.

  • Any current or past medical condition that represents a contra-indication to nicotine administration.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hadassah Medical Organization Jerusalem Israel

Sponsors and Collaborators

  • Hadassah Medical Organization

Investigators

  • Principal Investigator: Avi Yakir, MD, Hadassah Medical Organization

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00429208
Other Study ID Numbers:
  • yakir@hmo
First Posted:
Jan 31, 2007
Last Update Posted:
Jan 31, 2007
Last Verified:
Jan 1, 2007

Study Results

No Results Posted as of Jan 31, 2007